Skip to main content
Log in

Salmeterol/fluticasone propionate saves in chronic asthma

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Doull I, Price D, Thomas M, Hawkins N, Stamuli E, Tabberer M, Gosden T, Rudge H.Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Current Medical Research and Opinion 23: 1147-1159, No. 5, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salmeterol/fluticasone propionate saves in chronic asthma. Pharmacoecon. Outcomes News 533, 5 (2007). https://doi.org/10.1007/BF03296124

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03296124

Keywords

Navigation